Feb 27, 2026 08:00AM
Feb 27, 2026 08:00AM
Feb 23, 2026 07:30AM
Feb 23, 2026 07:30AM
Feb 16, 2026 05:31PM
Feb 12, 2026 07:30AM
Jan 16, 2026 09:12PM Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque
Nov 17, 2025 04:04PM
Nov 17, 2025 05:30AM
Nov 17, 2025 05:30AM
Nov 10, 2025 07:30AM
Nov 8, 2025 08:00AM
Sep 19, 2025 06:00AM
Sep 19, 2025 06:00AM European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
Sep 2, 2025 05:31AM
Sep 2, 2025 05:30AM
Aug 5, 2025 07:30AM
Jul 7, 2025 07:31AM
Jul 7, 2025 07:30AM
May 27, 2025 07:34AM
May 27, 2025 07:30AM US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection
May 1, 2025 07:00AM
Apr 1, 2025 07:31AM
Apr 1, 2025 07:30AM
Mar 28, 2025 06:00AM
Mar 10, 2025 12:01AM
Mar 8, 2025 09:00AM
Feb 13, 2025 07:30AM Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024
Dec 16, 2024 07:30AM
Dec 16, 2024 07:30AM
Nov 5, 2024 07:29AM
Nov 5, 2024 07:29AM
Oct 30, 2024 06:05AM
Oct 30, 2024 06:00AM
Oct 28, 2024 09:25AM Organon (OGN) Completes Acquisition of Dermavant
Oct 28, 2024 09:25AM
Sep 23, 2024 04:27PM
Sep 18, 2024 07:30AM
Sep 18, 2024 07:30AM
Feb 20, 2024 08:03AM
Feb 20, 2024 08:00AM
Nov 7, 2023 04:16PM Organon (OGN) and Samsung Bioepis Announce FDA Acceptance of sBLA for Interchangeability Designation for HADLIMA
Nov 7, 2023 04:15PM
Nov 7, 2023 04:15PM
Sep 14, 2023 05:12PM
Aug 1, 2023 07:02AM
Aug 1, 2023 07:00AM
Aug 1, 2023 07:00AM
Jul 5, 2023 08:00AM Daré Bioscience Provides Update on Activities to Support Commercial Launch of XACIATO™ (clindamycin phosphate) vaginal gel, 2%, FDA-Approved Treatment for Females 12 and Older with Bacterial Vagino
Jan 5, 2023 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All